While the stock dropped nearly 57% from the peaks observed in early February 2025 following a report from a short-seller ...

This decline has been fueled by a mixed macroeconomic environment, somewhat cautious near-term forecasts from the company ...

Follow all the latest U.S. market action for Tuesday here as stocks sit just shy of record highs despite turmoil in the Middle East and the Federal Reserve begins its two-day policy meeting.

Verve Therapeutics stock jumped after a report said pharmaceutical giant Eli Lilly is in advanced talks to buy the ...

US stock futures fell with investors on edge as Israel and Iran continued to trade strikes against a backdrop of shifting US ...

US households are expected to scoop up a total of $425 billion in stocks this year, according to Goldman Sachs analysts.

Despite the Fed's reluctance to cut rates immediately, ample liquidity in the banking system supports further economic and ...

Investors are regaining some appetite for risk amid rising optimism that the conflict won't spill over into a broader ...

Investors and the wider public are looking for answers after Thursday’s crash of an Air India 787 jet. Both of the plane’s ...

Sarepta Therapeutics shares sank to their lowest level in nine years Monday after a second patient taking its Elevidys drug ...

China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds ...

Financial concern is spiking among Americans, as 25.5 percent of the population fears a Wall Street meltdown, says report.